Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 "boost versus no boost"

Translated title of the contribution: Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 "boost versus no boost"

S. Collette, L. Collette, T. Budiharto, J.C. Horiot, P. Poortmans, H. Struikmans, W. van den Bogaert, A. Fourquet, J.J. Jager, W.J. Hoogenraad, R.P. Müller, J. Kurtz, D.A. Morgan, J.B. Dubois, E. Salamon, R. Mirimanoff, M. Bolla, M.E. van der Hulst, C.C. Warlam-Rodenhuis, H. Bartelink

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPredictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 "boost versus no boost"
Original languageUndefined/Unknown
Pages (from-to)2587-2599
Number of pages13
JournalEuropean Journal of Cancer
Volume44
Issue number17
Publication statusPublished - 2008

Cite this